(Q36521192)

14 August 2017

title

Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

14 August 2017

main subject

0 references

author name string

Dustin G James

1

1 reference

14 August 2017

Christian D Stone

2

1 reference

14 August 2017

Hanlin L Wang

3

1 reference

14 August 2017

William F Stenson

4

1 reference

14 August 2017

publication date

1 July 2006

1 reference

Inflammatory Bowel Diseases

14 August 2017

published in

1 reference

14 August 2017

volume

12

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

573-580

1 reference

Reactive hemophagocytic syndrome--a clinicopathologic study of 40 patients in an Oriental population

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Hemophagocytic syndrome (HPS) in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Review article: the limitations of corticosteroid therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Fever and progressive pancytopenia in a 20-year-old woman with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Methods to avoid infections in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Review article: Infliximab therapy for inflammatory bowel disease--seven years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Complications of biological therapy for inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Pathogenesis of hemophagocytic syndrome (HPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Bone marrow biopsy in hemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Macrophage activation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Laboratory assessment of immune function in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Changes in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000225333.83861.16

10.1097/01.MIB.0000225333.83861.16

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference